Merck’s Keytruda reaches coveted postsurgery lung cancer use with broader FDA nod than Tecentriq aliu Fri, 01/27/2023 – 09:25 More: Merck’s Keytruda reaches coveted postsurgery lung cancer use with broader FDA nod than Tecentriq Source: fierce
read moreClinical study is researching patients with diabetes and advanced chronic kidney disease More: Orbsen announces results from Nephstrom trial Source: News
read moreTherapy involves patients with paediatric-onset hypophosphatasia – a rare bone disease More: NICE recommends Alexion’s asfotase alfa across England Source: News
read moreAbortion pill maker GenBioPro sues West Virginia over abortion ban zbecker Thu, 01/26/2023 – 14:38 More: Abortion pill maker GenBioPro sues West Virginia over abortion ban Source: fierce
read moreBMS settles lawsuit with two fired employees who refused COVID vaccines kdunleavy Thu, 01/26/2023 – 14:30 More: BMS settles lawsuit with two fired employees who refused COVID vaccines Source: fierce
read moreBristol Myers makes case for Breyanzi in chronic lymphocytic leukemia. Will it make a difference? aliu Thu, 01/26/2023 – 10:30 More: Bristol Myers makes case for Breyanzi in chronic lymphocytic leukemia. Will it make a difference? Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals